UK (English)

Automated room disinfection technology

Nosocomial pathogens like Clostridium difficile, MRSA and VRE continue to cause problems in hospitals. The growth of antibiotic-resistant bacteria is now a global problem with experts and world leaders worried about the onset of a post-antibiotic age and escalating costs.

In particular, there are major clinical challenges linked to Gram-negative bacteria which are responsible for numerous healthcare-associated infections (HAIs). The number of viable antibiotics are going down fast, particularly for the treatment of problematic Gram-negative bacteria including Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa.Klebsiella

Eliminating pathogens, eliminating doubt

Research shows that ensuring successful eradication of all pathogens from the environment is essential to reduce HAIs. Bioquell’s automated room disinfection technology ensures all high-touch surfaces are decontaminated.

Bioquell’s unique hydrogen peroxide vapour (HPV) bio-decontamination technology works. It has been shown to reduce HAI rates in numerous independent, published scientific studies as well as ‘real-world’ deployments at top hospitals such as Johns Hopkins (USA). The threat of increasing antibiotic resistance has driven the development of the new Bioquell BQ-50 – which draws upon all of Bioquell’s ‘microorganism’ eradication expertise and experience.

Related pages

The latest in automated room disinfection technology, the BQ-50 eliminates pathogens and reduces HAIs

Learn more about the Bioquell BQ-50

The BQ-50 can be used to provide rapid ‘emergency’ response – or planned regular ‘bioquelling’ of high risk locations.

Find out about how the Bioquell BQ-50 can help in hospitals